Trial · NCT06314620
Normal Saline Flushing With And Without Heparin Lock In Maintaining Small Bore Intercostal Chest Catheter (ICC) Patency
NCT06314620, Not applicable, Completed, National University of Malaysia
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Normal Saline Flushing With And Without Heparin Lock In Maintaining Small Bore Intercostal Chest Catheter (ICC) Patency. Trials, record NCT06314620. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT06314620
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Normal Saline Flushing With And Without Heparin Lock In Maintaining Small Bore Intercostal Chest Catheter (ICC) Patency
- NCT number
- NCT06314620
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 40 participants, actual
- Lead sponsor
- National University of Malaysia
- Conditions
- Pleural Effusion
- Interventions
- Heparin saline lock, Without heparin saline lock
- First posted
- 2024-03-18
- Last updated
- 2026-09-15
Source ClinicalTrials.gov
Registered outcomes6
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | To compare the rate (in percentage) of occlusions of intercostal chest catheter in participants underwent normal saline flushing with and without heparin lock | From the time of randomization to the time of the end of study up to 30 days post insertion of chest drain | Participants who underwent intercostal chest catheter insertion who received normal saline flushing with and without heparin lock. |
| Secondary | To determine the onset of intercostal chest catheter occlusions (in hours) | From the time of randomization to the time of the end of study up to 30 days post insertion of chest drain | Participants who underwent intercostal chest catheter insertion who received normal saline flushing with and without heparin lock. |
| Secondary | To determine the change of hemoglobin (in g/dL) post ICC insertion | From the time of randomization to the time of the end of study up to 30 days post insertion of chest drain | Participants who underwent intercostal chest catheter insertion who received normal saline flushing with and without heparin lock. |
| Secondary | To determine the change of platelet (in 10 9/L) post ICC insertion | From the time of randomization to the time of the end of study up to 30 days post insertion of chest drain | Participants who underwent intercostal chest catheter insertion who received normal saline flushing with and without heparin lock. |
| Secondary | To determine the adverse effects of heparin saline lock | From the time of randomization to the time of the end of study up to 30 days post insertion of chest drain | Participants who underwent intercostal chest catheter insertion who received normal saline flushing with and without heparin lock. |
| Secondary | To assess the number of fenestrations occluded (in numbers from 0-5) with fibrin or blood clots | From the time of randomization to the time of the end of study up to up to 30 days post insertion of chest drain | Participants who underwent intercostal chest catheter insertion who received normal saline flushing with and without heparin lock. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers11
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT06314620
GET https://conductscience.org/api/trials/v1/NCT06314620/registered